We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Webinar

Cancer Immunotherapies Landscape: Challenges and Future

On-Demand
Speaking at The Landscape of Cancer Research 2022 online symposium, Sofia Lourenco of Cancer Research Horizons delivered her talk on the challenges facing the future of cancer immunotherapies.
Webinar

Next-Generation STING Agonists for Immunotherapy Against Advanced Cancer

On-Demand
Speaking at The Landscape of Cancer Research 2022 online symposium, James Moon from the University of Michigan delivered his talk on next-generation STING agonists for immunotherapy against advanced cancer.
Webinar

Advancing CRISPR Gene Editing for Solid Tumors Toward Clinical Application

On-Demand
Speaking at The Landscape of Cancer Research 2022 online symposium, Eric Kmiec of the Gene Editing Institute, ChristianaCare, delivered his talk on advances in CRISPR gene editing.
Webinar

Recent Advances and Challenges in Oncolytic Virotherapy: The Myoxma Virus Story

On-Demand
Speaking at The Landscape of Cancer Research 2022 online symposium, keynote speaker Grant McFadden of the University of Arizona delivered his talk on recent advances and challenges in oncolytic virotherapy.
Webinar

Discovering and Categorizing Mutational Signatures From Cancer Whole Genomes

On-Demand
Speaking at The Landscape of Cancer Research 2022 online symposium, Andrea Degasperi of the Early Cancer Institute, University of Cambridge, delivered his talk on mutational signatures discovery and categorization from whole cancer genomes.
Webinar

Looking to the Future of Cell and Gene Therapies

On-Demand
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Advertisement